Integra LifeSciences (IART) Competitors $24.10 +0.86 (+3.70%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IART vs. ITGR, ATRC, ATEC, OFIX, SRDX, ANGO, ARAY, RMTI, RSLS, and ABTShould you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Integer (ITGR), AtriCure (ATRC), Alphatec (ATEC), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), and Abbott Laboratories (ABT). These companies are all part of the "health care equipment" industry. Integra LifeSciences vs. Integer AtriCure Alphatec Orthofix Medical Surmodics AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Integra LifeSciences (NASDAQ:IART) and Integer (NYSE:ITGR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, community ranking, institutional ownership, valuation, analyst recommendations, risk and media sentiment. Does the MarketBeat Community prefer IART or ITGR? Integra LifeSciences received 49 more outperform votes than Integer when rated by MarketBeat users. However, 63.92% of users gave Integer an outperform vote while only 56.83% of users gave Integra LifeSciences an outperform vote. CompanyUnderperformOutperformIntegra LifeSciencesOutperform Votes43756.83% Underperform Votes33243.17% IntegerOutperform Votes38863.92% Underperform Votes21936.08% Do institutionals & insiders believe in IART or ITGR? 84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 3.1% of Integra LifeSciences shares are owned by company insiders. Comparatively, 2.0% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts rate IART or ITGR? Integra LifeSciences presently has a consensus target price of $23.00, indicating a potential downside of 4.56%. Integer has a consensus target price of $145.44, indicating a potential upside of 3.22%. Given Integer's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Integra LifeSciences 3 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75Integer 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Which has better valuation & earnings, IART or ITGR? Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntegra LifeSciences$1.54B1.21$67.74M-$0.09-267.75Integer$1.60B2.96$90.65M$3.2443.49 Which has more volatility & risk, IART or ITGR? Integra LifeSciences has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Is IART or ITGR more profitable? Integer has a net margin of 6.70% compared to Integra LifeSciences' net margin of -0.42%. Integra LifeSciences' return on equity of 12.35% beat Integer's return on equity.Company Net Margins Return on Equity Return on Assets Integra LifeSciences-0.42% 12.35% 4.82% Integer 6.70%11.63%5.86% Does the media favor IART or ITGR? In the previous week, Integra LifeSciences had 4 more articles in the media than Integer. MarketBeat recorded 5 mentions for Integra LifeSciences and 1 mentions for Integer. Integer's average media sentiment score of 0.76 beat Integra LifeSciences' score of 0.17 indicating that Integer is being referred to more favorably in the news media. Company Overall Sentiment Integra LifeSciences Neutral Integer Positive SummaryInteger beats Integra LifeSciences on 13 of the 18 factors compared between the two stocks. Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IART vs. The Competition Export to ExcelMetricIntegra LifeSciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.68B$4.51B$5.22B$8.94BDividend YieldN/A47.30%5.13%4.04%P/E Ratio-267.7526.2989.7217.34Price / Sales1.2158.321,251.2178.56Price / Cash4.5250.1443.8235.97Price / Book1.197.795.324.79Net Income$67.74M$13.87M$122.69M$225.00M7 Day Performance10.50%1.46%-0.16%1.52%1 Month Performance8.75%11.95%3.75%4.68%1 Year Performance-43.15%53.01%27.41%20.89% Integra LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IARTIntegra LifeSciences3.5318 of 5 stars$24.10+3.7%$23.00-4.6%-42.5%$1.68B$1.54B-267.753,946Short Interest ↓ITGRInteger2.7648 of 5 stars$134.73+0.7%$145.44+8.0%+35.5%$4.52B$1.71B41.5810,500ATRCAtriCure1.9181 of 5 stars$34.19+8.9%$42.00+22.8%+15.1%$1.67B$447.57M-41.191,200ATECAlphatec4.4361 of 5 stars$10.91+9.4%$17.44+59.9%-23.4%$1.55B$572.74M-8.52700Analyst ForecastInsider TradeHigh Trading VolumeOFIXOrthofix Medical2.7242 of 5 stars$17.33+1.9%$23.00+32.7%+36.3%$662.25M$784.25M-5.541,090Insider TradeNews CoverageSRDXSurmodics4.2277 of 5 stars$36.01-6.3%$50.00+38.9%+10.3%$514.73M$126.08M-44.46450Analyst ForecastNews CoverageANGOAngioDynamics4.0079 of 5 stars$12.45+1.2%$13.00+4.4%+111.0%$505.89M$292.73M-2.04760Short Interest ↓News CoverageGap DownARAYAccuray4.4617 of 5 stars$2.15+0.5%$9.00+318.6%-19.4%$216.22M$444.20M-12.651,040Short Interest ↑RMTIRockwell Medical4.3251 of 5 stars$2.04-1.9%$6.00+194.1%+47.2%$65.93M$98.92M-40.80300Short Interest ↓News CoveragePositive NewsRSLSReShape Lifesciences1.1526 of 5 stars$5.17+14.9%N/A-65.5%$3.69M$8.18M0.0050Short Interest ↓Positive NewsGap UpHigh Trading VolumeABTAbbott Laboratories4.7556 of 5 stars$112.69+0.3%$131.57+16.8%-0.4%$195.46B$41.22B34.25115,000Options VolumeNews Coverage Related Companies and Tools Related Companies ITGR Alternatives ATRC Alternatives ATEC Alternatives OFIX Alternatives SRDX Alternatives ANGO Alternatives ARAY Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IART) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
